Literature DB >> 20474002

Tumour growth following portal branch ligation in an experimental model of liver metastases.

O Kollmar1, M Corsten, C Scheuer, B Vollmar, M K Schilling, M D Menger.   

Abstract

BACKGROUND: Portal branch ligation (PBL) is being used increasingly before hepatectomy for colorectal metastases. This study evaluated the effect of PBL on angiogenesis, growth factor expression and tumour growth in a mouse model of hepatic colorectal metastases.
METHODS: CT26.WT cells were implanted into the left liver lobe of BALB/c mice. Animals underwent PBL of the left liver lobe or sham treatment. Angiogenesis, microcirculation, growth factor expression, cell proliferation and tumour growth were studied over 14 and 21 days by intravital multifluorescence microscopy, laser Doppler flowmetry, immunohistochemistry and western blotting.
RESULTS: Left hilar blood flow and tumour microcirculation were significantly diminished during the first 7 days after PBL. This resulted in tumour volume being 20 per cent less than in sham controls by day 14. Subsequently, PBL-treated animals demonstrated recovery of left hilar blood flow and increased expression of hepatocyte growth factor and transforming growth factor alpha, associated with increased cell proliferation and acceleration of growth by day 21.
CONCLUSION: PBL initially reduced vascular perfusion and tumour growth, but this was followed by increased growth factor expression and cell proliferation. This resulted in delayed acceleration of tumour growth, which might explain the stimulated tumour growth observed occasionally after PBL.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20474002     DOI: 10.1002/bjs.7003

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  6 in total

1.  Portal branch ligation does not counteract the inhibiting effect of temsirolimus on extrahepatic colorectal metastatic growth.

Authors:  Sebastian Senger; Jens Sperling; Barbara Oberkircher; Martin K Schilling; Otto Kollmar; Michael D Menger; Christian Ziemann
Journal:  Clin Exp Metastasis       Date:  2017-06-19       Impact factor: 5.150

2.  Tumour growth of colorectal rat liver metastases is inhibited by hepatic arterial infusion of the mTOR-inhibitor temsirolimus after portal branch ligation.

Authors:  Jens Sperling; Christian Ziemann; Anika Gittler; Anna Benz-Weißer; Michael D Menger; Otto Kollmar
Journal:  Clin Exp Metastasis       Date:  2015-02-19       Impact factor: 5.150

Review 3.  Liver regeneration biology: Implications for liver tumour therapies.

Authors:  Christopher Hadjittofi; Michael Feretis; Jack Martin; Simon Harper; Emmanuel Huguet
Journal:  World J Clin Oncol       Date:  2021-12-24

Review 4.  Tumour progression and liver regeneration--insights from animal models.

Authors:  Chetana Lim; Francois Cauchy; Daniel Azoulay; Olivier Farges; Maxime Ronot; Marc Pocard
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2013-04-09       Impact factor: 46.802

Review 5.  A systematic review of two-stage hepatectomy in patients with initially unresectable colorectal liver metastases.

Authors:  Vincent W T Lam; Jerome M Laurence; Emma Johnston; Michael J Hollands; Henry C C Pleass; Arthur J Richardson
Journal:  HPB (Oxford)       Date:  2012-11-07       Impact factor: 3.647

6.  Role of portal vein embolization in hepatocellular carcinoma management and its effect on recurrence: a case-control study.

Authors:  Rohan C Siriwardana; Chung Mau Lo; See Ching Chan; Sheung Tat Fan
Journal:  World J Surg       Date:  2012-07       Impact factor: 3.352

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.